Canopy Growth Corp. (CGC)

36.59
NYSE : Process Industries
Prev Close 35.56
Day Low/High 35.75 / 36.74
52 Wk Low/High 24.21 / 59.25
Avg Volume 5.05M
Exchange NYSE
Shares Outstanding 343.58M
Market Cap 12.36B
EPS -2.00
P/E Ratio N/A
Div & Yield N.A. (N.A)
What You Need to Watch: Cramer's 'Mad Money' Recap (Thursday 4/4/19)

What You Need to Watch: Cramer's 'Mad Money' Recap (Thursday 4/4/19)

Jim Cramer warns: Don't blink or you'll miss this market movement. He looks at what's got investors' attention: Boeing, China, retailers and rotations.

Constellation Brands Focuses on Beer, Tesla Deliveries Underwhelm

Constellation Brands Focuses on Beer, Tesla Deliveries Underwhelm

What I do know is that TSLA now faces a tumultuous uphill battle in order to meet its full year guidance.

2 Important Earnings Reports I'm Watching This Week

2 Important Earnings Reports I'm Watching This Week

What to look for when Dave & Buster's and Constellation Brands report results.

Stock Picking Comeback: Cramer's 'Mad Money' Recap (Thursday 3/28/19)

Stock Picking Comeback: Cramer's 'Mad Money' Recap (Thursday 3/28/19)

Lots of IPOs and innovation will reward investors who do their homework, Jim Cramer says.

Seth Rogen Partners With Canopy Growth to Get You to Love Recreational Weed

Seth Rogen Partners With Canopy Growth to Get You to Love Recreational Weed

Seth Rogen is an actor and avid cannabis smoker and his Houseplant brand is a partnership with Canopy Growth.

Canopy Growth Welcomes Houseplant To The Family

Canopy Growth Welcomes Houseplant To The Family

VANCOUVER, March 27, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to welcome Houseplant, a new brand of Canadian cannabis, to the Canopy Growth family today.

Welcome To Houseplant, An Elevated Canadian Cannabis Company

Welcome To Houseplant, An Elevated Canadian Cannabis Company

Focused on product and quality, education and guidance VANCOUVER, March 27, 2019 /CNW/ - Today marks the official launch of Houseplant, a new brand of recreational Canadian cannabis founded by Seth Rogen and Evan Goldberg in collaboration with Canopy...

Canopy Growth Receives New Health Canada Licence In Atlantic Canada That Will Boost Output, Create Jobs

Canopy Growth Receives New Health Canada Licence In Atlantic Canada That Will Boost Output, Create Jobs

New $40M production facility will increase Canopy Growth's cannabis output by more than 5,000kg annually, create more than 130 jobs in Fredericton, NB SMITHS FALLS, ON and FREDERICTON, NB, March 25, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED...

2 Big Earnings Reports I'll Be Watching This Week

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

Don't Be a Hero: Cramer's 'Mad Money' Recap (Friday 3/22/19)

Don't Be a Hero: Cramer's 'Mad Money' Recap (Friday 3/22/19)

Jim Cramer says there's so much money being run by computers, stocks are virtually destined to come down in this situation. Here's the game plan.

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Canopy Growth Acquires Hemp Company To Accelerate Expansion In The United States

Canopy Growth Acquires Hemp Company To Accelerate Expansion In The United States

Hemp pioneer Geoff Whaling to join Canopy Growth USA as Strategic Advisor, Hemp and CBD in addition to being the co-Founder and President of Hemp Developments LLC.

Canopy Growth Announces Multi-year Extraction Agreement With Victoria-based HollyWeed North Cannabis Inc.

Canopy Growth Announces Multi-year Extraction Agreement With Victoria-based HollyWeed North Cannabis Inc.

SMITHS FALLS, ON and VICTORIA, BC, March 20, 2019 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company") and HollyWeed Manufacturing & Extracts Inc.

What Metric Jim Cramer Watches in Every Cannabis Earnings Report

What Metric Jim Cramer Watches in Every Cannabis Earnings Report

Overwhelmed by the cannabis earnings reports? Here's the metric that Jim Cramer watches.

The Fed's March Meeting: 3 Things Stock Investors Should Look Out For

The Fed's March Meeting: 3 Things Stock Investors Should Look Out For

Plus, why investors should care about the yield curve, and a closer look at Tilray's quarter.

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Pot Stocks Trade Mixed Following Tilray's Fourth-Quarter Results

Tilray shares turn following the company's fourth-quarter results while other pot stocks trade mixed.

With Tilray, You Won't Win Any Valuation Arguments

With Tilray, You Won't Win Any Valuation Arguments

Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.

Trading Tilray Stock's Wild Post-Earnings Volatility

Trading Tilray Stock's Wild Post-Earnings Volatility

Tilray's wide trading range on Tuesday is relatively calm considering the important levels it's teetering on.

Why Jim Cramer Believes Canopy Could Be the Next Amazon

Why Jim Cramer Believes Canopy Could Be the Next Amazon

Jim Cramer said that he believes that Canopy Growth could be the next Amazon. Here's why he thinks that the cannabis company could be the next Amazon.

Tilray Is Not My Favorite Canadian Cannabis Stock

Tilray Is Not My Favorite Canadian Cannabis Stock

Apparently, this game is all about growth right now. It certainly is not about margins.

Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space

Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space

Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

Tilray Stock Lights Up as Partnerships Obscure Profitability Problem

The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.

Canopy Growth And DNA Genetics Extend And Expand Relationship

Canopy Growth And DNA Genetics Extend And Expand Relationship

SMITHS FALLS, ON and LOS ANGELES, CA, March 19, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy") (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or the "Company"), a world-leading, diversified cannabis company and OG DNA Genetics ("DNA"), a globally...

Here's How Tilray Is Doing Ahead of Monday's Earnings Release

Here's How Tilray Is Doing Ahead of Monday's Earnings Release

Tilray is expected to increase its revenue by more than 50% from the previous quarter.

The Future of Cannabis: Edibles & Oil Based Products

The Future of Cannabis: Edibles & Oil Based Products

When it comes to products related to cannabis consumption, a rich universe of options continues to scale up around oils and edibles.

Chart of the Day: Vetting the Value of Cannabis Companies

Chart of the Day: Vetting the Value of Cannabis Companies

Assessing Aurora and its peers, strictly on the numbers.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz Is the Perfect Problem Solver for Aurora Cannabis

Peltz's addition should pacify a persistent critique of the company.

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' Is a Beast but the Stock Has Entered a Tricky Area Now

Aurora Cannabis' hiring of deal maker Nelson Peltz opens up a wealth of new possibilities for the Canadian pot company.

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

Jim Cramer: Buy Aurora Cannabis Because Nelson Peltz Knows What Can Go Right

I know that Nelson is fascinated by the medicinal properties chiefly as a replacement for opioids, the scourge of this country.

TheStreet Quant Rating: C- (Hold)